1478 related articles for article (PubMed ID: 19089938)
1. PCI versus CABG for multivessel coronary disease in diabetics.
Tarantini G; Ramondo A; Napodano M; Favaretto E; Gardin A; Bilato C; Nesseris G; Tarzia V; Cademartiri F; Gerosa G; Iliceto S
Catheter Cardiovasc Interv; 2009 Jan; 73(1):50-8. PubMed ID: 19089938
[TBL] [Abstract][Full Text] [Related]
2. Complete versus incomplete revascularization in patients with multivessel disease undergoing percutaneous coronary intervention with drug-eluting stents.
Tamburino C; Angiolillo DJ; Capranzano P; Dimopoulos K; La Manna A; Barbagallo R; Tagliareni F; Mangiafico S; Guzman LA; Galassi AR; Bass TA
Catheter Cardiovasc Interv; 2008 Oct; 72(4):448-56. PubMed ID: 18814218
[TBL] [Abstract][Full Text] [Related]
3. CABG versus DES PCI in diabetics with multivessel disease: back to the BARI registry.
Hillegass W
Catheter Cardiovasc Interv; 2009 Jan; 73(1):59-60. PubMed ID: 19089939
[No Abstract] [Full Text] [Related]
4. Multivessel coronary revascularization in patients with and without diabetes mellitus: 3-year follow-up of the ARTS-II (Arterial Revascularization Therapies Study-Part II) trial.
Daemen J; Kuck KH; Macaya C; LeGrand V; Vrolix M; Carrie D; Sheiban I; Suttorp MJ; Vranckx P; Rademaker T; Goedhart D; Schuijer M; Wittebols K; Macours N; Stoll HP; Serruys PW;
J Am Coll Cardiol; 2008 Dec; 52(24):1957-67. PubMed ID: 19055986
[TBL] [Abstract][Full Text] [Related]
5. Nonrandomized comparison of coronary artery bypass surgery and percutaneous coronary intervention for the treatment of unprotected left main coronary artery disease in octogenarians.
Rodés-Cabau J; Deblois J; Bertrand OF; Mohammadi S; Courtis J; Larose E; Dagenais F; Déry JP; Mathieu P; Rousseau M; Barbeau G; Baillot R; Gleeton O; Perron J; Nguyen CM; Roy L; Doyle D; De Larochellière R; Bogaty P; Voisine P
Circulation; 2008 Dec; 118(23):2374-81. PubMed ID: 19029471
[TBL] [Abstract][Full Text] [Related]
6. Coronary artery bypass surgery versus percutaneous coronary intervention with drug-eluting stent implantation in patients with multivessel coronary disease.
Yang ZK; Shen WF; Zhang RY; Kong Y; Zhang JS; Hu J; Zhang Q; Ding FH
J Interv Cardiol; 2007 Feb; 20(1):10-6. PubMed ID: 17300391
[TBL] [Abstract][Full Text] [Related]
7. Multivessel drug-eluting stenting and impact of diabetes mellitus--a report from the EVENT registry.
Novack V; Tsyvine D; Cohen DJ; Pencina M; Dubin J; Dehghani H; Kleiman NS; Cutlip DE
Catheter Cardiovasc Interv; 2009 Jun; 73(7):874-80. PubMed ID: 19180665
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with drug-eluting stents for patients with multivessel coronary artery disease.
Javaid A; Steinberg DH; Buch AN; Corso PJ; Boyce SW; Pinto Slottow TL; Roy PK; Hill P; Okabe T; Torguson R; Smith KA; Xue Z; Gevorkian N; Suddath WO; Kent KM; Satler LF; Pichard AD; Waksman R
Circulation; 2007 Sep; 116(11 Suppl):I200-6. PubMed ID: 17846304
[TBL] [Abstract][Full Text] [Related]
9. Early and long-term outcomes after surgical and percutaneous myocardial revascularization in patients with non-ST-elevation acute coronary syndromes and unprotected left main disease.
Buszman PP; Bochenek A; Konkolewska M; Trela B; Kiesz RS; Wilczyński M; Cisowski M; Krejca M; Banasiewicz-Szkróbka I; Krol M; Kondys M; Wiernek S; Orlik B; Martin JL; Tendera M; Buszman PE
J Invasive Cardiol; 2009 Nov; 21(11):564-9. PubMed ID: 19901409
[TBL] [Abstract][Full Text] [Related]
10. Meta-analysis of studies comparing coronary artery bypass grafting with drug-eluting stenting in patients with diabetes mellitus and multivessel coronary artery disease.
Lee MS; Yang T; Dhoot J; Iqbal Z; Liao H
Am J Cardiol; 2010 Jun; 105(11):1540-4. PubMed ID: 20494658
[TBL] [Abstract][Full Text] [Related]
11. Coronary artery bypass surgery versus percutaneous coronary artery intervention in patients on chronic hemodialysis: does a drug-eluting stent have an impact on clinical outcome?
Manabe S; Shimokawa T; Fukui T; Fumimoto KU; Ozawa N; Seki H; Takanashi S
J Card Surg; 2009; 24(3):234-9. PubMed ID: 19438773
[TBL] [Abstract][Full Text] [Related]
12. Long-term mortality after percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass surgery for the treatment of multivessel coronary artery disease.
Park DW; Yun SC; Lee SW; Kim YH; Lee CW; Hong MK; Kim JJ; Choo SJ; Song H; Chung CH; Lee JW; Park SW; Park SJ
Circulation; 2008 Apr; 117(16):2079-86. PubMed ID: 18413495
[TBL] [Abstract][Full Text] [Related]
13. Coronary artery bypass surgery is superior to percutaneous coronary intervention with drug-eluting stents for patients with chronic renal failure on hemodialysis.
Sunagawa G; Komiya T; Tamura N; Sakaguchi G; Kobayashi T; Murashita T
Ann Thorac Surg; 2010 Jun; 89(6):1896-900; discussion 1900. PubMed ID: 20494045
[TBL] [Abstract][Full Text] [Related]
14. Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial.
Kapur A; Hall RJ; Malik IS; Qureshi AC; Butts J; de Belder M; Baumbach A; Angelini G; de Belder A; Oldroyd KG; Flather M; Roughton M; Nihoyannopoulos P; Bagger JP; Morgan K; Beatt KJ
J Am Coll Cardiol; 2010 Feb; 55(5):432-40. PubMed ID: 20117456
[TBL] [Abstract][Full Text] [Related]
15. Comparison of coronary artery bypass surgery with percutaneous coronary intervention with drug-eluting stents for unprotected left main coronary artery disease.
Lee MS; Kapoor N; Jamal F; Czer L; Aragon J; Forrester J; Kar S; Dohad S; Kass R; Eigler N; Trento A; Shah PK; Makkar RR
J Am Coll Cardiol; 2006 Feb; 47(4):864-70. PubMed ID: 16487857
[TBL] [Abstract][Full Text] [Related]
16. Coronary artery bypass grafting versus drug-eluting stents in multivessel coronary disease. A meta-analysis on 24,268 patients.
Benedetto U; Melina G; Angeloni E; Refice S; Roscitano A; Fiorani B; Di Nucci GD; Sinatra R
Eur J Cardiothorac Surg; 2009 Oct; 36(4):611-5. PubMed ID: 19394857
[TBL] [Abstract][Full Text] [Related]
17. Balancing benefit against risk in the choice of therapy for coronary artery disease. Lesson from prospective, randomized, clinical trials of percutaneous coronary intervention and coronary artery bypass graft surgery.
Morrison DA; Sacks J
Minerva Cardioangiol; 2003 Oct; 51(5):585-97. PubMed ID: 14551526
[TBL] [Abstract][Full Text] [Related]
18. Prognosis of percutaneous coronary intervention and coronary artery bypass grafts for ostial right coronary lesions in propensity-matched individuals.
Gan HL; Zhang JQ; Huang F; Gu CX; Kong QY; Cao XR; Bo P; Lu CS
Cardiovasc Ther; 2011 Dec; 29(6):395-403. PubMed ID: 20718758
[TBL] [Abstract][Full Text] [Related]
19. Diabetic and nondiabetic patients with left main and/or 3-vessel coronary artery disease: comparison of outcomes with cardiac surgery and paclitaxel-eluting stents.
Banning AP; Westaby S; Morice MC; Kappetein AP; Mohr FW; Berti S; Glauber M; Kellett MA; Kramer RS; Leadley K; Dawkins KD; Serruys PW
J Am Coll Cardiol; 2010 Mar; 55(11):1067-75. PubMed ID: 20079596
[TBL] [Abstract][Full Text] [Related]
20. Outcomes after percutaneous coronary intervention of ostial lesions in the era of drug-eluting stents.
Freeman M; Clark DJ; Andrianopoulos N; Duffy SJ; Lim HS; Brennan A; Charter K; Shaw J; Horrigan M; Ajani AE; Sebastian M; Reid CM; Farouque HM;
Catheter Cardiovasc Interv; 2009 May; 73(6):763-8. PubMed ID: 19309731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
